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238Objectives: Because some concern has been raised about the storage time of red blood cells and outcomes after
cardiac surgery, we investigated whether longer storage time of transfused plasma increases the risk for early or
late mortality among patients who have undergone coronary artery bypass grafting.
Methods: We retrospectively analyzed the data of all 10,626 patients who underwent isolated coronary artery
bypass grafting in Catharina Hospital, Eindhoven, The Netherlands, between January 1998 and December 2007.
All patients who received at least 1 unit of plasma intraoperatively or during the first 5 postoperative days were
studied. Theywere divided into 3 groups (only younger plasma, only older plasma, and any older plasma groups)
according to the storage time of the plasma (cutoff point, 323 days).
Results: After we had excluded 122 patients who were unavailable for follow-up, we found that 375 of the re-
maining patients (n ¼ 745) received only younger plasma 370 patients received any older plasma, and 200 pa-
tients received only older plasma (mean follow-up, 1565  1137 days; median follow-up, 1629 days). The
storage time of plasma, when entered as either a continuous variable or a dichotomous variable, was a risk factor
for early but not late mortality. Log-rank testing revealed no statistical difference in long-term survival among
the groups.
Conclusions: Longer storage time of plasma is a risk factor for early but not late mortality among patients who
have undergone coronary artery bypass grafting. (J Thorac Cardiovasc Surg 2011;141:238-43)Supplemental material is available online.
Critically ill patients, including thosewhohaveundergone car-
diac surgery, often have more severe complications if they
have received a blood transfusion during the perioperative
period.1,2 The storage time of red blood cells may influence
the risk of such complications,3-8 because these cells
undergo structural and functional changes that can reduce
their function and viability after transfusion.8-10 Recently,
some11 but not all12,13 authors have expressed concern about
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heterogeneous patient populations have been mentioned.
The transfusion of fresh-frozen plasma (FFP) from female
donors can lead to transfusion-related acute lung injury.14-19
To our knowledge, no data regarding the effect of the storage
time of transfused FFP on early and late outcomes after
coronary artery bypass grafting are available. We therefore
studied whether the storage time of transfused FFP
increases the risk for early or late mortality in a large
group of patients who underwent coronary artery bypass
grafting in a single center.MATERIALS AND METHODS
Patients
This study included the data from all adult patients who underwent iso-
lated coronary artery bypass grafting in Catharina Hospital, Eindhoven,
The Netherlands, between January 1998 and December 2007. Data collec-
tion was initiated in January 1998, when clinical information (demographic
data, risk factors, and complications) for the study subjects was prospec-
tively collected in a database.
Study Design
Approval was obtained from the institution’s research review board.
Data on blood transfusions and the storage time of FFP were collected
from the database of the hospital transfusion service. All patients who
had received at least 1 unit of FFP between the day of operation and the
5th postoperative day were included in this study. Patients who had
received more than 10 units of red blood cells were excluded from the anal-
ysis. The maximum time of storage of the transfused FFP per patient wasery c January 2011
Abbreviation and Acronym
FFP ¼ fresh-frozen plasma
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groups according to the storage time of FFP: patients who received only
FFP that had been stored for less than 323 days (the younger FFP group),
patients who received only FFP that had been stored for at least 323 days
(the only older FFP group), and patients who received a least 1 unit of older
FFP (the any older FFP group). We used a cutoff point of 323 days because
that was the median maximum storage time of all FFP transfused in this
study. Patients in the only older FFP group were also included in the any
older FFP group.
Operative Technique
All patients received short-acting anesthetic drugs to facilitate early
extubation. Normothermic extracorporeal circulation was performed with
nonpulsatile flow. Either cold crystalloid cardioplegia (St. Thomas solu-
tion) or warm blood cardioplegia, according to the surgeon’s preference,
was used to induce and maintain cardioplegic arrest. All patients who
underwent coronary artery bypass grafting with the use of extracorporeal
circulation received low-dose aprotinin (2 million kallikrein inactivation
units) during extracorporeal circulation that was administered in the prime
solution of the heart–lung machine, as was the usual practice in our hospi-
tal. Patients who underwent off-pump surgery did not receive aprotinin.
Storage of FFP
After withdrawal of the donor blood, the plasma was frozen and stored
for at least 6 months at30C before it was released for transfusion. During
those 6 months, the donor was tested for viral diseases. The maximum al-
lowed storage time is 2 years.
Follow-up
Follow-up data on the mortality of the patients studied were gathered
from the databases of Dutch health insurance companies. Initially, the
data for 9% of the total patient group could not be retrieved from those da-
tabases. We then contacted the general practitioners of those subjects to ob-
tain the required mortality data. If necessary, we also contacted the
authorities of the city in which those patients lived at the time of surgery.
Postoperative mortality was defined as early (30 days) or late (>30 days).
Indication for Transfusion of FFP
The main indication for plasma transfusion in our center is excessive
postoperative bleeding caused by coagulation disorder. FFP was given if
1 or more of the following laboratory tests yielded abnormal results: acti-
vated partial thromboplastin time, prothrombin time, international normal-
ized ratio, and fibrinogen level. The choice to transfuse old or young FFP
was made randomly, without any previously agreed protocol.
Statistical Analyses
Discrete variables were compared with the c2 test and are presented as
numbers and percentages of patients. Continuous variables were compared
with the t test and analysis of variance and are presented as the mean SD.
Univariate and multivariate logistic regression analyses were performed to
investigate the impact of biomedical variables on early mortality. Multivar-
iate analyses were used to test for the potentially confounding effects of
biomedical and demographic factors on outcome. Cox proportional hazard
regression analyses were performed for the same analyses of late mortality.
If they were significant, confounders were included in multivariate logistic
and Cox regression analyses.The Journal of Thoracic and CaFactors that were significant in the univariate analyses were entered into
a multivariate model, together with the items of interest (the number of
transfused FFP units and the maximum storage time per patient as a contin-
uous variable and as a dichotomous variable). The following 3 factors were
entered in 3 separate models, together with other variables: maximum stor-
age time of FFP, only older FFP, and any older FFP. Long-term survival was
described with the Kaplan–Meier method. A comparison of long-term sur-
vival was performed with log-rank statistics. The zero time point indicated
the time of coronary artery bypass grafting. Odds ratios and hazard ratios
with 95% confidence intervals are reported. All statistical analyses were
performed with SPSS software (Statistical Product and Service Solutions,
version 15.0; SSPS Inc, an IBM Company, Chicago, Ill).RESULTS
During a 10-year period (January 1998–December 2007)
10,626 patients underwent coronary artery bypass grafting
in our hospital. Excluded from the analysis were patients
who were unavailable for follow-up (n ¼ 122) and those
who received more than 10 units of red blood cells
(n ¼ 80). Of the remaining patients, 375 received only
younger FFP, 370 received any older FFP, and 200 patients
received only older FFP. The mean follow-up was 1565 
1137 days (range, 0–3704 days), with follow-up considered
0 days in cases of operative death. The median follow-up
was 1506 days, the mean storage time for FFP was 341 
94 days (range, 196–730 days), and the median storage
time for FFP was 323 days. The distribution of FFP storage
times is shown in Figure E1.
Baseline characteristics stratified by storage time are
shown in Table 1. None of the differences among the patient
groups in baseline characteristics was significant except for
re-exploration, which occurred more often among patients
who had received only younger FFP, and the numbers of
transfused units of FFP and platelets, which were higher
among patients who had received any older FFP. Only the
number of units of transfused platelets was higher in the
group of patients who had received only older FFP.
Early mortality occurred more often among patients who
received older FFP (ie, in 7.0% of those who received any
older FFP and in 9.0% of those who received only older
FFP) than in patients who received younger FFP (3.2%),
as shown in Table E1. Univariate logistic regression analy-
ses (Table E2) revealed that the maximum storage time of
FFP was a significant risk factor for early mortality, both
as a continuous variable and as a dichotomous variable
with a cutoff point of 323 days (only older FFP plasma
and any older FFP versus younger FFP). Other risk factors
for early mortality were age, chronic obstructive pulmonary
disease, diabetes, low creatinine clearance, a left ventricular
ejection fraction lower than 35%, a low preoperative hemo-
globin level, previous cardiac surgery, emergency opera-
tion, perioperative myocardial infarction, and the numbers
of units of transfused red blood cells, FFP, and platelets.
Univariate Cox regression analyses did not reveal the max-
imum storage time of FFP as a risk factor for late mortality.rdiovascular Surgery c Volume 141, Number 1 239
TABLE 1. Baseline characteristics stratified by storage age of fresh-frozen plasma transfused
Younger FFP
(N ¼ 375)
Any older FFP
(N ¼ 370) P value
Only older FFP
(N ¼ 200) P value
Preoperative factors
Age (y, mean  SD) 65.0  9.4 65.7  9.9 .288 66.4  9.3 .088
Male (no.) 305 (81.3%) 307 (83.0%) .313 164 (82.0%) .470
Diabetes (no.) 76 (20.3%) 69 (18.6%) .321 37 (18.5%) .348
Hypertension (no.) 146 (38.9%) 134 (36.2%) .245 83 (41.5%) .305
Chronic obstructive pulmonary disease (no.) 45 (12.0%) 50 (13.5%) .305 29 (14.4%) .234
Peripheral vascular disease (no.) 48 (12.8%) 44 (11.9%) .396 28 (14.0%) .388
Left ventricular ejection fraction<35% (no.) 12 (3.4%) 18 (5.3%) .163 6 (3.2%) .560
Creatinine clearance (mL/min, mean  SD) 71.2  23.9 70.5  23.9 .690 70.1  24.3 .606
Emergency (no.) 46 (12.3%) 49 (13.2%) .386 29 (14.5%) .263
Preoperative hemoglobin (g/dL, mean  SD) 13.7  1.5 13.8  1.4 .414 13.6  1.1 .494
Cardiac reoperation (no.) 55 (14.7%) 52 (14.1%) .447 28 (14.0%) .467
Perioperative and postoperative factors
No of grafts (mean  SD) 3.3  1.2 3.4  1.1 .471 3.3  1.1 .708
Off pump (no.) 26 (6.9%) 26 (7.0%) .537 18 (9.0%) .233
Extracorporeal circulation time
(min, mean  SD)
66.2  44.0 65.4  42.9 .798 65.2  45.6 .786
Intra-aortic balloon pump (no.) 32 (8.5%) 30 (8.1%) .469 15 (7.5%) .398
Re-exploration (no.) 134 (35.7%) 120 (32.4%) .191 50 (25.0%) .005
Perioperative myocardial infarction (no.) 32 (8.5%) 28 (7.6%) .364 14 (7.0%) .318
Red blood cells (units, mean  SD) 3.7  2.7 3.8  2.8 .740 3.3  2.5 .066
FFP (units, mean  SD) 2.5  1.1 2.8  1.5 .001 2.4  1.1 .409
Platelets (units, mean  SD) 0.29  0.56 0.46  0.81 .001 0.42  0.75 .016
FFP, Fresh-frozen plasma.
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MFactors that were significant for late mortality were age,
chronic obstructive pulmonary disease, diabetes, low creat-
inine clearance, low preoperative hemoglobin level, previ-
ous cardiac surgery, peripheral vascular disease,
hypertension, perioperative myocardial infarction, and the
numbers of units of transfused red blood cells and FFP.
All risk factors that were identified in univariate analyses
were entered into the multivariate logistic regression and
multivariate Cox regression models (Table 2).
Early Mortality
The maximum storage time of FFP, when entered as
a continuous and as a dichotomous variable with a cutoff
point of 323 days (only older FFP and any older FFP versus
younger FFP), was identified as an independent risk factor
for early mortality. Because the numbers of red blood
cell, FFP and platelet units were entered into the multivari-
ate model, this effect was independent of the number of
transfusion of blood products. The number of transfused
platelet units was not significant as a predictor of early mor-
tality. Other independent risk factors for early mortality
were as follows: diabetes, a left ventricular ejection fraction
less than 35%, and perioperative myocardial infarction.
Late Mortality
The maximum storage time of FFP, when entered as ei-
ther a continuous variable or a dichotomous variable with240 The Journal of Thoracic and Cardiovascular Surga cutoff point of 323 days (older versus younger FFP),
was not identified as an independent risk factor for late mor-
tality. Independent risk factors for late mortality were the
number of transfused FFP units, age, chronic obstructive
pulmonary disease, diabetes, low preoperative hemoglobin
level, and perioperative myocardial infarction. The number
of transfused platelet units was not significant in the univar-
iate analysis for late mortality and therefore was not entered
into the multivariate analysis.
Figure E1 shows the normal distribution of maximum
storage time of FFP per patient. The predicted probability
for early mortality increased with storage time for all pa-
tients, as well as for patients who received 1 or 2 units of
FFP, as shown in Figures 1 and 2.
The survival curves of patients who received a transfusion
only of younger FFP and those who received any older FFP
are shown in Figure E2. The survival curves of those pa-
tients who received a transfusion of younger FFP and of
those who received only older FFP are shown in Figure 3.
The differences between the curves did not reach statistical
significance. It is clear, however, that there is a distinct dif-
ference in the early postoperative period.DISCUSSION
This retrospective study shows that the transfusion of
older FFP is an independent risk factor for early but not
late mortality. The study population consisted of patientsery c January 2011
TABLE 2. Multivariate logistic regression analyses for early mortality and Cox regression analyses for late mortality
Early mortality Late mortality
Risk factor OR 95% CI P value HR 95% CI P value
FFP maximum storage time* 1.004 1.001–1.008 .023 1.001 0.998–1.003 .622
Any older FFP 2.29 1.00–5.22 .048 0.93 0.62–1.51 .104
Only older FFP 3.43 1.32–8.92 .011 0.78 0.42–1.43 .159
Red blood cell units transfused* 1.067 0.902–1.261 .451 0.931 0.852–1.016 .110
FFP units transfused* 1.025 0.785–1.338 .856 1.347 1.165–1.558 < .0001
Platelet units transfused* 1.406 0.847–2.332 .188
Age* 1.022 0.972–1.075 .401 1.048 1.016–1.081 .003
Chronic obstructive pulmonary disease 1.83 0.72–1.07 .201 2.68 1.67–4.31 < .0001
Diabetes 3.34 1.46–7.62 .004 1.75 1.10–2.79 .018
Creatinine clearance* 0.995 0.974–1.016 .640 0.986 0.972–1.001 .064
Left ventricular ejection fraction<35% 3.65 1.08–12.29 .036
Preoperative hemoglobin* 0.837 0.649–1.079 .170 0.860 0.744–0.995 .043
Cardiac reoperation 1.74 0.68–4.47 .244 1.57 0.95–2.61 .078
Peripheral vascular disease 1.40 0.81–2.42 .216
Emergency 2.22 0.68–7.18 .183
Perioperative myocardial infarction 4.11 1.54–10.95 .005 3.62 2.00–6.56 < .0001
HR, Hazard ratio; CI, confidence interval; OR, odds ratio; FFP, fresh-frozen plasma. *Entered as a continuous variable.
FIGURE 1. Predicted probability for early mortality for all patients. FFP,
Fresh-frozen plasma.
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of red blood cells intraoperatively or within the first 5 post-
operative days after coronary artery bypass grafting. Pa-
tients who received more than 10 units of red blood cells
were excluded from this study. The reason is that most of
these patients had massive blood loss as a result of surgical
calamities that caused various complications, including
death. Thus the outcome in such cases was mainly influ-
enced by the major surgical insult. The decision to transfuse
younger or older FFP was random, according to the avail-
ability of the FFP. The cutoff point for younger and older
FFP of 323 days (the median storage time) was arbitrary.
In the multivariate logistic regression analyses, the maxi-
mum storage time used both as a continuous variable and
as a dichotomous variable was revealed as an independent
risk factor. The year of operation did not prove to be an in-
dependent risk factor for early mortality, and the storage
protocol did not change with time. This indicates a real ef-
fect of storage age on early mortality. The predicted proba-
bility for early mortality increased with longer per patient
maximum storage time. The same was found for patients
who received 1 or 2 units of FFP. This confirms the results
of the multivariate regression analyses, which showed the
storage time to be an independent risk factor.
Although the late mortalities were less in the any older
FFP group and the only older FFP group, multivariate anal-
yses revealed that late mortality was not influenced by the
storage time of FFP. Surprisingly, the numbers of units of
transfused red blood cells, FFP, and platelets did not prove
to be a risk factor for early mortality. This can be probably
explained by the fact that in this subgroup of patients who
received FFP, the mean number of transfused red blood
cell units was already high (mean 3.6 2.6 units). The trans-The Journal of Thoracic and Cafusion of additional red blood cells in those patients did not
increase the risk for mortality or morbidity any further.
In previous reports, transfusion-related acute lung injury
has been described,14-19 The authors of those reports
suggested that leukocyte antibodies and FFP from female
donors might be important risk factors for the development
of transfusion-related acute lung injury in critically ill
patients. A recent report,20 however, did not support this
finding.
To our knowledge, no data are available regarding the ef-
fect of the storage time of FFP on short-term and long-term
outcomes after coronary artery bypass grafting. We found
a clear relationship between the storage time of FFP andrdiovascular Surgery c Volume 141, Number 1 241
FIGURE 2. Predicted probability for early mortality for patients with 1 to
2 units of fresh-frozen plasma (FFP).
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tween patients who received younger FFP and those who
received older FFP. To further eliminate the effect of con-
founders, multivariate analyses were performed. The results
of those analyses led to the conclusion that the transfusion
of older FFP resulted in a poorer early outcome but that
there was no relationship between the storage time of FFP
and late outcome. The predicted probability for early mor-
tality increased with longer per patient maximum FFP stor-
age time. The samewas found for patients who received 1 or
2 units of FFP. This confirms the results of the multivariateFollow-Up Time in Days
40003000200010000
C
u
m
 
S
u
r
v
i
v
a
l
1,0
0,9
0,8
0,7
0,6
0,5
only older FFP
younger FFP
p = .288
FIGURE 3. Kaplan–Meier curves for patients receiving younger or only
older fresh-frozen plasma (FFP). Cum, Cumulative.
242 The Journal of Thoracic and Cardiovascular Surgregression analyses, which showed that the FFP storage
time was an independent risk factor.
It has been demonstrated that prothrombin time and acti-
vated partial thromboplastin time are influenced by freezing
and storage. This effect is more pronounced at20C than at
70C.21 Factor VIII levels are influenced by the storage
temperature after thawing22,23 or after storage without
freezing.24 It has also been shown that slow freezing causes
a more pronounced decrease in the level of factor VIII than
does more rapid freezing.25 In The Netherlands, blood prod-
ucts are stored at30C. At that temperature, the degenera-
tion of clotting factors and other proteins cannot be
excluded. Degeneration may lead to less effective clotting
factors, and the degenerated proteins may produce unknown
adverse effects. This possible progressive degeneration of
proteins might be the reason that our subjects who received
older FFP had relatively worse outcomes. Further studies
are needed to investigate the possible progressive degener-
ation of proteins. Because most transfused FFP is older than
300 days, it might be advantageous to use younger FFP for
transfusion whenever possible until that issue has been fur-
ther clarified.Study Limitations
In this retrospective study, factors not included in the list
of demographic characteristics may explain the differences
between the patient groups. A prospective, randomized trial
should resolve that shortcoming. The primary end point of
the study was all-cause mortality. Unfortunately, we were
not able to retrieve the causes of death for these patients,
data that are equally important. Moreover, the effects of
storage time of FFP on postoperative complications such
as sepsis or pulmonary complications remain unknown.
Correlation between the storage time of FFP and postoper-
ative bleeding and re-exploration was also not determined.
This is another important shortcoming.
This investigation was a single-center study performed in
The Netherlands. Whether our results can be applied to cor-
onary artery bypass grafting performed in other countries in
which different protocols for blood withdrawal, processing,
and storage are practiced remains to be determined.CONCLUSIONS
In a study of the 745 of 10,626 patients undergoing coro-
nary artery bypass grafting who received FFP intraopera-
tively or within the first 5 postoperative days after coronary
artery bypass grafting, we found that the longer storage
time of FFP was an independent risk factor for early but
not late mortality.
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FIGUREE1. Distribution ofmaximum (per patient) storage time of fresh-
frozen plasma (FFP).
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FIGURE E2. Kaplan –Meier curves for patients receiving only younger
or any older fresh-frozen plasma (FFP).
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TABLE E2. Univariate logistic regression analyses of risk factors for early mortality and Cox regression analyses for late mortality
Early mortality Late mortality
Risk factor OR 95% CI P value HR 95% CI P value
Preoperative factors
Age* 1.043 1.005–1.082 .027 1.077 1.051–1.104 < .0001
Male sex 0.65 0.31–1.37 .264 0.72 0.45–1.14 .169
Chronic obstructive pulmonary disease 2.34 1.11–4.96 .026 2.43 1.53–3.84 < .0001
Diabetes 2.54 1.31–4.94 .006 1.97 1.28–3.04 .002
Creatinine clearance* 0.977 0.961–0.992 .003 0.969 0.958–9.979 < .0001
Left ventricular ejection fraction<35% 4.20 1.50–11.73 .014 2.03 0.88–4.65 .093
Preoperative hemoglobin* 0.702 0.577–0.855 < .0001 0.767 0.671–0.877 < .0001
Cardiac reoperation 3.40 1.72–6.73 .001 1.78 1.11–2.86 .017
Peripheral vascular disease 1.78 0.80–4.00 .120 2.21 1.35–3.61 .001
Emergency 3.52 1.75–7.07 .001 1.54 0.89–2.66 .122
Hypertension 1.18 0.62–2.25 .355 1.50 1.01–2.23 .045
Perioperative and postoperative factors
No. of grafts* 0.825 0.634–1.074 .152 1.003 0.857–1.175 .970
Perioperative myocardial infarction 3.04 1.33–6.91 .013 3.03 1.80–5.12 < .0001
Re-exploration 0.79 0.39–1.57 .313 0.93 0.62–1.40 .745
Off pump 1.47 0.50–4.31 .476 0.77 0.28–2.10 .616
Year of operation 0.972 0.975–1.080 .596 0.961 0.879–1.052 .390
FFP maximum storage time* 1/004 1.001–1.007 .005 1.001 0.999–1.003 .294
Any older FFP 2.57 1.29–5.12 .007 0.98 0.66–1.47 .943
Only older FFP 2.99 1.41–6.34 .004 0.80 0.46–1.39 .439
FFP units transfused 1.264 1.074–1.487 .005 1.239 1.096–1.400 .001
Platelet units transfused 1.698 1.228–2.347 .001 1.183 0.893–1.566 .242
Red blood cell units transfused 1.220 1.091–1.364 < .0001 1.089 1.016–1.168 .016
OR, Odds ratio; CI, confidence interval; HR, hazard ratio; FFP, fresh-frozen plasma. *Entered as a continuous variable.
TABLE E1. Early and late mortalities among patients receiving younger and older fresh-frozen plasma
Younger FFP Any older FFP P value* Only older FFP P value*
Early mortality (no.) 12 (3.2%) 29 (7.8%) .004 18 (9.0%) .003
Late mortality (no.) 58 (15.5%) 43 (11.6%) .077 17 (8.5%) .011
FFP, Fresh-frozen plasma. *Versus younger fresh-frozen plasma.
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